These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 10899226)

  • 21. Biperiden enhances L-DOPA methyl ester and dopamine D(l) receptor agonist SKF-82958 but antagonizes D(2)/D(3) receptor agonist rotigotine antihemiparkinsonian actions.
    Domino EF; Ni L
    Eur J Pharmacol; 2008 Dec; 599(1-3):81-5. PubMed ID: 18851961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homologous desensitization of the D1A dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency.
    Lewis MM; Watts VJ; Lawler CP; Nichols DE; Mailman RB
    J Pharmacol Exp Ther; 1998 Jul; 286(1):345-53. PubMed ID: 9655879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of an alpha-2 adrenergic agonist, guanfacine, on rCBF in human cortex in normal controls and subjects with focal epilepsy.
    Swartz BE; Kovalik E; Thomas K; Torgersen D; Mandelkern MA
    Neuropsychopharmacology; 2000 Sep; 23(3):263-75. PubMed ID: 10942850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia.
    Farré D; Muñoz A; Moreno E; Reyes-Resina I; Canet-Pons J; Dopeso-Reyes IG; Rico AJ; Lluís C; Mallol J; Navarro G; Canela EI; Cortés A; Labandeira-García JL; Casadó V; Lanciego JL; Franco R
    Mol Neurobiol; 2015 Dec; 52(3):1408-1420. PubMed ID: 25344317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Procaine-induced increases in limbic rCBF correlate positively with increases in occipital and temporal EEG fast activity.
    Parekh PI; Spencer JW; George MS; Gill DS; Ketter TA; Andreason P; Herscovitch P; Post RM
    Brain Topogr; 1995; 7(3):209-16. PubMed ID: 7599020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function.
    Heidenreich BA; Mitrovic I; Battaglia G; Napier TC
    Exp Neurol; 2004 Apr; 186(2):145-57. PubMed ID: 15026253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
    Rowlett JK; Platt DM; Yao WD; Spealman RD
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excitatory actions of dopamine via D1-like receptors in the rat lateral geniculate nucleus.
    Govindaiah G; Cox CL
    J Neurophysiol; 2005 Dec; 94(6):3708-18. PubMed ID: 16107529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine D1 receptor coupling to Gs/olf and Gq in rat striatum and cortex: a scintillation proximity assay (SPA)/antibody-capture characterization of benzazepine agonists.
    Mannoury la Cour C; Vidal S; Pasteau V; Cussac D; Millan MJ
    Neuropharmacology; 2007 Mar; 52(3):1003-14. PubMed ID: 17178132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
    Barrett AC; Miller JR; Dohrmann JM; Caine SB
    Neuropharmacology; 2004; 47 Suppl 1():256-73. PubMed ID: 15464142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of endogenous GABA release by an antagonistic adenosine A1/dopamineD1 receptor interaction in rat brain limbic regions but not basal ganglia.
    Mayfield RD; Jones BA; Miller HA; Simosky JK; Larson GA; Zahniser NR
    Synapse; 1999 Sep; 33(4):274-81. PubMed ID: 10421708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging dopamine D4 receptors in the living primate brain: a positron emission tomography study using the novel D1/D4 antagonist [11C]SDZ GLC 756.
    Boy C; Klimke A; Holschbach M; Herzog H; Mühlensiepen H; Rota Kops E; Sonnenberg F; Gaebel W; Stöcklin G; Markstein R; Müller-Gärtner HW
    Synapse; 1998 Dec; 30(4):341-50. PubMed ID: 9826226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
    Mittleman G; Rosner AL; Schaub CL
    J Pharmacol Exp Ther; 1994 Nov; 271(2):638-50. PubMed ID: 7965779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
    Ralph RJ; Caine SB
    J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motor response to a dopamine D3 receptor preferring agonist compared to apomorphine in levodopa-primed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
    Blanchet PJ; Konitsiotis S; Chase TN
    J Pharmacol Exp Ther; 1997 Nov; 283(2):794-9. PubMed ID: 9353400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of the effects of the cannabinoid agonist, ACPA, on spatial and non-spatial novelty detection in mice by dopamine D1 receptor drugs infused into the basolateral amygdala.
    Mohammadi M; Nasehi M; Zarrindast MR
    Behav Brain Res; 2015 Mar; 280():36-44. PubMed ID: 25476564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys.
    Desai RI; Neumeyer JL; Paronis CA; Nguyen P; Bergman J
    Eur J Pharmacol; 2007 Mar; 558(1-3):98-106. PubMed ID: 17207791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats.
    Ohmura Y; Jutkiewicz EM; Zhang A; Domino EF
    Pharmacol Biochem Behav; 2011 Oct; 99(4):552-6. PubMed ID: 21624384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.